Skip to content

Therapeutic Area

Oncology Clinical Research Organization (CRO) Services

Roya Clinical Solutions LLC supports oncology and cell and gene therapy clinical trials for biotech and pharmaceutical sponsors, including autologous CAR-T programs. Hire us for a full program or for individual functions.

Where Oncology Trials Need Extra Care

Patient Material on a Schedule

In autologous CAR-T trials, each patient's cells travel from apheresis to manufacturing and back. We qualify sites and couriers, coordinate manufacturing slots and vein-to-vein scheduling, and protect chain of identity and custody.

Specialist Safety Oversight

Physician-led medical monitoring, with CRS/ICANS management training and toxicity algorithms, SAE/SUSAR processing and DSMB/IDMC support.

Regulatory Scrutiny

IND, CTA and IMPD dossiers, health-authority meetings and clinical hold responses, including CAR-T work with the FDA and other agencies.

Oncology Trial Capabilities

One team covers regulatory, clinical, safety, data and quality.

Regulatory Affairs

IND, CTA and IMPD dossiers; FDA, EMA and global health-authority submissions and meetings; clinical hold responses; import/export and ethics approvals.

Medical Writing

Protocols, Investigator's Brochures, informed consent forms, Clinical Study Reports and regulatory responses.

Clinical Operations

Global feasibility, site selection and start-up, risk-based monitoring, project management, TMF management and vendor oversight.

Cell & Gene Therapy Trial Support

Apheresis site qualification, chain of identity and custody, courier qualification and mock shipments, and long-term follow-up (LTFU) programs.

Site Services

Training, contracts, payments and quality support for investigator sites.

Cell and Gene Therapy

CAR-T and Cell Therapy Delivery

Our team has worked on autologous CAR-T trials, where each patient's cells go from apheresis to manufacturing and back on a tight schedule. We qualify sites and couriers, run mock shipments, protect chain of identity and custody, and set up long-term follow-up.

CAR-T and Cell Therapy Trial Support

What We Take On

  • Apheresis and treatment-site qualification
  • Chain of identity and chain of custody
  • Vein-to-vein logistics and mock shipments
  • CRS/ICANS safety oversight
  • 15-year long-term follow-up

Data Management and Biostatistics

  • EDC build, data cleaning and coding
  • CDISC SDTM/ADaM datasets, define.xml and reviewer's guides
  • Statistical analysis plans, interim and final analyses, and TLFs

Geographic Experience

Our team's CAR-T trial experience runs from early phase to Phase II in the United States, Europe, the Middle East (including Saudi Arabia), Turkey and Latin America. For other oncology studies, we run global feasibility across countries and indications.

  • United States
  • Europe
  • Middle East (including Saudi Arabia)
  • Turkey
  • Latin America

Phases and Ways to Work

Phase I to IV, from first-in-human studies through post-approval.

Full-Service
We run the whole program, from feasibility to the final report.
Functional Support
We take on specific functions, such as regulatory submissions, medical monitoring, data management or audits, alongside your team.

Who Leads Your Study

Our programs are led by physicians and pharmacists, and sponsors work directly with senior people throughout the study.

Separately, our co-founders' own careers include multinational trials in oncology and hematologic malignancies, cell and gene therapies and rare diseases. That is their individual experience, described in their biographies.

Meet Our Leadership

Frequently Asked Questions

What services does an oncology CRO provide?

An oncology CRO plans and runs cancer clinical trials for sponsors. At Roya that covers development strategy, regulatory submissions, medical writing, clinical operations, medical monitoring and pharmacovigilance, data management, biostatistics and quality assurance, as a full program or as individual services.

How does Roya support autologous CAR-T logistics?

We qualify apheresis and treatment sites and couriers, run mock shipments, coordinate manufacturing slots and vein-to-vein scheduling, and manage chain of identity and chain of custody for each patient's cells.

What trial phases can Roya support?

Phase I to IV, from first-in-human studies through post-approval and real-world evidence. Our team's CAR-T experience runs from early phase to Phase II.

How is chain of identity managed?

We manage chain of identity and chain of custody so each patient's cells are tracked from apheresis through courier transport and manufacturing, and back to the treatment site, supported by validated clinical technology for cell therapy.

What sponsor engagement models are available?

Full-service, where we run the whole program from feasibility to the final report, or functional support, where we take on specific functions such as regulatory submissions, medical monitoring, data management or audits alongside your team.

Let’s Advance Your Clinical Development Program

Planning a new trial, expanding an ongoing study or looking for specialized support? Talk to our leadership team about your goals.

Contact

info@royaclinical.com (689) 588-6006

1650 Sand Lake Rd, Suite 201, Orlando, FL 32809

Cookie Preferences

Choose which optional cookies to allow. You can change this later under Cookie Settings in the footer.

Cookie categories
Always On

Remembers your cookie choice. Required for the site to work.

Google Analytics shows us which pages are visited and how people find the site. It sets cookies (_ga) and stays off unless you turn it on.

For advertising and campaign measurement. Not currently in use.